InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more
InspireMD Inc (NSPR) - Total Assets
Latest total assets as of September 2025: $78.47 Million USD
Based on the latest financial reports, InspireMD Inc (NSPR) holds total assets worth $78.47 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
InspireMD Inc - Total Assets Trend (2008–2024)
This chart illustrates how InspireMD Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
InspireMD Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
InspireMD Inc's total assets of $78.47 Million consist of 86.6% current assets and 13.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 40.4% |
| Accounts Receivable | $2.25 Million | 4.8% |
| Inventory | $2.57 Million | 5.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how InspireMD Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: InspireMD Inc's current assets represent 86.6% of total assets in 2024, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 40.4% of total assets in 2024, down from 100.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 5.5% of total assets.
InspireMD Inc Competitors by Total Assets
Key competitors of InspireMD Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
InspireMD Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - InspireMD Inc generates 0.15x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - InspireMD Inc is currently not profitable relative to its asset base.
InspireMD Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.51 | 6.39 | 4.14 |
| Quick Ratio | 6.17 | 6.05 | 3.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $59.58 Million | $ 39.13 Million | $ 11.63 Million |
InspireMD Inc - Advanced Valuation Insights
This section examines the relationship between InspireMD Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.15 |
| Latest Market Cap to Assets Ratio | 0.80 |
| Asset Growth Rate (YoY) | -1.8% |
| Total Assets | $46.81 Million |
| Market Capitalization | $37.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values InspireMD Inc's assets below their book value (0.80 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: InspireMD Inc's assets decreased by 1.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for InspireMD Inc (2008–2024)
The table below shows the annual total assets of InspireMD Inc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $46.81 Million | -1.75% |
| 2023-12-31 | $47.64 Million | +93.25% |
| 2022-12-31 | $24.65 Million | -37.92% |
| 2021-12-31 | $39.71 Million | +123.39% |
| 2020-12-31 | $17.78 Million | +79.93% |
| 2019-12-31 | $9.88 Million | -19.60% |
| 2018-12-31 | $12.29 Million | +101.21% |
| 2017-12-31 | $6.11 Million | -35.10% |
| 2016-12-31 | $9.41 Million | +62.86% |
| 2015-12-31 | $5.78 Million | -49.58% |
| 2014-12-31 | $11.46 Million | -44.76% |
| 2013-12-31 | $20.75 Million | +29.54% |
| 2012-12-31 | $16.01 Million | +0.02% |
| 2012-06-30 | $16.01 Million | -0.02% |
| 2011-12-31 | $16.01 Million | +269314.54% |
| 2010-12-31 | $5.94K | 0.00% |
| 2009-12-31 | $5.94K | +20.69% |
| 2008-12-31 | $4.92K | -- |